Indications for: LYMPHAZURIN
An adjunct to lymphography (in primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; and lymph node response to therapeutic modalities) for visualization of the lymphatic system draining the region of injection.
Give by SC inj. 0.5mL into 3 interdigital spaces of each extremity per study. Max dose 3mL (30mg).
Hypersensitivity to triphenylmethane.
Have emergency equipment available for at least 30–60 minutes after injection. Urine color may be blue for 24hrs post administration. Pregnancy (Cat.C). Nursing mothers.
Do not mix with local anesthetics (eg, lidocaine) in the same syringe; precipitation results.
Local reactions, pruritus; anaphylaxis possible.
Single-dose vial (5mL)—1